Category: Side Effect: Vision / Optical (blindness, macular edema, sudden vision loss)
-
Invokana, Farxiga, Jardiance, Other SGLT2 Inhibitors Associated With Retinal Vein Occlusion
Increased Risk for This New Vision/Eyes Side Effect Highest in Elderly Patients and Chronic Kidney Disease Patients (Posted by Tom Lamb at Drug Injury Watch) In June 2021 it was reported that Invokana, Farxiga, and…
-
Beovu Vision Loss Side Effects Continue to Plague Novartis, Ending 3 Key Clinical Trials in May 2021
And Novartis "has yet to identify the root cause behind Beovu’s safety problem", According to a News Report (Posted by Tom Lamb at Drug Injury Watch) Starting back in February 2020, when the American Society…
-
Beovu Vision Loss Lawsuits Involve Serious Eye Problems Due to Beovu Injections Reactions
People Need to Know Beovu Lawsuits Are Filed as Individual Cases; No Beovu Class Actions for Beovu Eye Problems (Posted by Tom Lamb at Drug Injury Watch) Starting in January 2021 Beovu…
-
Beovu Side Effects Have Caused Eye Doctors to Avoid Beovu and Use Other Safer AMD Drugs Instead
In Addition, the Three New Beovu Lawsuits Filed for Patients with Vision Loss May Further Impact Novartis Market Share (Posted by Tom Lamb at Drug Injury Watch) Since being approved by the…
-
Elmiron Maculopathy Secondary to Pentosan Polysulfate (PPS) Toxicity: Medical Journal Article
New Elmiron Study Suggests Established Maculopathy Patients Should be Asked About Possible Elmiron Use (Posted by Tom Lamb at Drug Injury Watch) Elmiron maculopathy secondary to pentosan polysulfate (PPS) toxicity was first…
-
Elmiron Pigmentary Maculopathy Risk Warning Issued by Janssen and Health Canada in December 2020
New Medical Article Describes How to Identify, Image, and Diagnose Pigmentary Maculopathy Caused by Elmiron Use (Posted by Tom Lamb at Drug Injury Watch) On December 15, 2020 a Dear Healthcare Professional…